文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

括约肌间瘘管结扎术和经直肠内推移皮瓣术治疗克罗恩病高位肛周瘘:一项回顾性队列研究。

Ligation of the Intersphincteric Fistula Tract and Endorectal Advancement Flap for High Perianal Fistulas in Crohn's Disease: A Retrospective Cohort Study.

机构信息

Department of Surgery, Amsterdam UMC, University of Amsterdam, Meibergdreef, Amsterdam,the Netherlands.

Department of Gastroenterology and Hepatology, Amsterdam UMC, University of Amsterdam, Meibergdreef, Amsterdam, the Netherlands.

出版信息

J Crohns Colitis. 2020 Jul 9;14(6):757-763. doi: 10.1093/ecco-jcc/jjz181.


DOI:10.1093/ecco-jcc/jjz181
PMID:31696918
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7346888/
Abstract

BACKGROUND AND AIMS: Ligation of the intersphincteric fistula tract [LIFT] and advancement flap [AF] procedures are well-established, sphincter-preserving procedures for closure of high perianal fistulas. As surgical fistula closure is not commonly offered in Crohn's disease patients, long-term data are limited. This study aims to evaluate outcomes after LIFT and AF in Crohn's high perianal fistulas. METHODS: All consecutive Crohn's disease patients ≥18 years old treated with LIFT or AF between January 2007 and February 2018 were included. The primary outcome was clinical healing and secondary outcomes included radiological healing, recurrence, postoperative incontinence and Vaizey Incontinence Score. RESULTS: Forty procedures in 37 patients [LIFT: 19, AF: 21, 35.1% male] were included. A non-significant trend was seen towards higher clinical healing percentages after LIFT compared to AF [89.5% vs 60.0%; p = 0.065]. Overall radiological healing rates were lower for both approaches [LIFT 52.6% and AF 47.6%]. Recurrence rates were comparable: 21.1% and 19.0%, respectively. In AF a trend was seen towards higher clinical healing percentages when treated with anti-tumour necrosis factor/immunomodulators [75.0% vs 37.5%; p = 0.104]. Newly developed postoperative incontinence occurred in 15.8% after LIFT and 21.4% after AF. Interestingly, 47.4% of patients had a postoperatively improved Vaizey Score [LIFT: 52.9% and AF: 42.9%]. The mean Vaizey Score decreased from 6.8 [SD 4.8] preoperatively to 5.3 [SD 5.0] postoperatively [p = 0.067]. CONCLUSIONS: Both LIFT and AF resulted in satisfactory closure rates in Crohn's high perianal fistulas. However, a discrepancy between clinical and radiological healing rates was found. Furthermore, almost half of the patients benefitted from surgical intervention with respect to continence.

摘要

背景与目的:括约肌间瘘管结扎术(LIFT)和推移皮瓣术(AF)是两种成熟的保留括约肌的高位肛周瘘管闭合术。由于在克罗恩病患者中并不常规采用外科瘘管闭合术,因此长期数据有限。本研究旨在评估 LIFT 和 AF 在克罗恩病高位肛周瘘中的应用效果。

方法:纳入 2007 年 1 月至 2018 年 2 月期间接受 LIFT 或 AF 治疗的年龄≥18 岁的克罗恩病患者。主要结局为临床愈合,次要结局包括影像学愈合、复发、术后失禁和 Vaizey 失禁评分。

结果:共纳入 37 例患者的 40 例手术(LIFT:19 例,AF:21 例,男性占 35.1%)。与 AF 相比,LIFT 的临床愈合率有升高的趋势,但差异无统计学意义[89.5%比 60.0%;p=0.065]。两种方法的影像学愈合率均较低[LIFT:52.6%,AF:47.6%]。复发率相当:21.1%和 19.0%。在 AF 中,与未使用抗 TNF/免疫调节剂相比,使用时的临床愈合率有升高的趋势[75.0%比 37.5%;p=0.104]。LIFT 后新发术后失禁发生率为 15.8%,AF 为 21.4%。有趣的是,47.4%的患者术后 Vaizey 评分得到改善[LIFT:52.9%,AF:42.9%]。术后 Vaizey 评分从术前的 6.8[SD 4.8]降至 5.3[SD 5.0](p=0.067)。

结论:LIFT 和 AF 均可使克罗恩病高位肛周瘘获得满意的闭合率,但临床愈合率与影像学愈合率之间存在差异。此外,近一半的患者的术后失禁情况得到改善。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab82/7346888/d3a604fd1c90/jjz181f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab82/7346888/d3a604fd1c90/jjz181f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab82/7346888/d3a604fd1c90/jjz181f0001.jpg

相似文献

[1]
Ligation of the Intersphincteric Fistula Tract and Endorectal Advancement Flap for High Perianal Fistulas in Crohn's Disease: A Retrospective Cohort Study.

J Crohns Colitis. 2020-7-9

[2]
Systematic review and meta-analysis of endorectal advancement flap and ligation of the intersphincteric fistula tract for cryptoglandular and Crohn's high perianal fistulas.

BJS Open. 2019-1-21

[3]
A prospective evaluation of the ligation of the intersphincteric tract procedure for complex anal fistula in patients with Crohn's disease.

Ann Surg. 2014-12

[4]
Long-term healing after complex anal fistula repair in patients with Crohn's disease.

Tech Coloproctol. 2020-8

[5]
Ligation of the Intersphincteric Fistula Tract for High Transsphincteric Fistula Yields Moderate Results at Best: Is the Tide Turning?

Dis Colon Rectum. 2019-10

[6]
Magnetic resonance imaging after ligation of the intersphincteric fistula tract for high perianal fistulas in Crohn's disease: a retrospective cohort study.

Colorectal Dis. 2021-1

[7]
Increasing experience with the LIFT procedure in Crohn's disease patients with complex anal fistula.

Tech Coloproctol. 2022-3

[8]
Perianal fistulas and the lift procedure: results, predictive factors for success, and long-term results with subsequent treatment.

Tech Coloproctol. 2019-7-17

[9]
Increasing experience of ligation of the intersphincteric fistula tract for patients with Crohn's disease: what have we learned?

Colorectal Dis. 2017-8

[10]
Ligation of intersphincteric fistula tract versus mucosal advancement flap in patients with high transsphincteric fistula-in-ano: a prospective randomized trial.

Dis Colon Rectum. 2014-10

引用本文的文献

[1]
Evaluation of the RIFER procedure in treating high intersphincteric anal fistulas.

Front Med (Lausanne). 2025-5-16

[2]
Failure rates and complications of four sphincter-sparing techniques for the treatment of fistula-in-ano: a systematic review and network meta-analysis.

Tech Coloproctol. 2025-5-20

[3]
Patient and Healthcare Professional Perspectives on Crohn's Perianal Fistula Treatment: Results From a Discrete Choice Experiment.

Crohns Colitis 360. 2025-1-4

[4]
Predictive modeling to evaluate long-term treatment effectiveness of darvadstrocel in patients with complex perianal fistulas in Crohn's disease.

BMC Gastroenterol. 2024-12-30

[5]
Perianal Fistula; from Etiology to Treatment - A Review.

Middle East J Dig Dis. 2024-4

[6]
[Not Available].

Tunis Med. 2024-4-5

[7]
TOpCLASS Expert Consensus Classification of Perianal Fistulising Crohn's Disease: A Real-world Application in a Serial Fistula MRI Cohort.

J Crohns Colitis. 2024-9-3

[8]
Multi-national observational study to assess quality of life and treatment preferences in patients with Crohn's perianal fistulas.

World J Gastrointest Surg. 2023-11-27

[9]
Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy alone for Crohn's perianal fistulas (PISA-II): long-term outcomes of an international, multicentre patient preference, randomised controlled trial.

EClinicalMedicine. 2023-7-5

[10]
Deep remission improves the quality of life of patients with Crohn's disease and anoperineal fistula treated with darvadstrocel: results of a French pilot study.

Tech Coloproctol. 2023-12

本文引用的文献

[1]
Systematic review and meta-analysis of endorectal advancement flap and ligation of the intersphincteric fistula tract for cryptoglandular and Crohn's high perianal fistulas.

BJS Open. 2019-1-21

[2]
The LIFT procedure for a perianal Crohn's fistula - a video vignette.

Colorectal Dis. 2019-7

[3]
Higher anti-TNF serum levels are associated with perianal fistula closure in Crohn's disease patients.

Scand J Gastroenterol. 2019-4

[4]
Vedolizumab as a rescue therapy for patients with medically refractory Crohn's disease.

Colorectal Dis. 2018-5-13

[5]
Efficacy of Medical Therapies for Fistulizing Crohn's Disease: Systematic Review and Meta-analysis.

Clin Gastroenterol Hepatol. 2018-1-31

[6]
Increasing experience of ligation of the intersphincteric fistula tract for patients with Crohn's disease: what have we learned?

Colorectal Dis. 2017-8

[7]
Higher infliximab trough levels are associated with perianal fistula healing in patients with Crohn's disease.

Aliment Pharmacol Ther. 2017-2-17

[8]
Optimization of anti-TNF therapy in patients with Inflammatory Bowel Disease.

Expert Rev Clin Pharmacol. 2016

[9]
Multimodal treatment of perianal fistulas in Crohn's disease: seton versus anti-TNF versus advancement plasty (PISA): study protocol for a randomized controlled trial.

Trials. 2015-8-20

[10]
Postinduction serum infliximab trough level and decrease of C-reactive protein level are associated with durable sustained response to infliximab: a retrospective analysis of the ACCENT I trial.

Gut. 2014-11

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索